ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 182 filers reported holding ARCUS BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,511,002 | -45.1% | 195,599 | -37.9% | 0.12% | -36.5% |
Q2 2023 | $6,394,319 | -39.2% | 314,836 | -45.4% | 0.20% | -38.4% |
Q1 2023 | $10,519,884 | +23.9% | 576,748 | +40.5% | 0.32% | +23.1% |
Q4 2022 | $8,488,726 | -5.5% | 410,480 | +19.6% | 0.26% | -11.3% |
Q3 2022 | $8,982,000 | +41.6% | 343,335 | +37.1% | 0.29% | +35.0% |
Q2 2022 | $6,345,000 | -11.1% | 250,385 | +10.8% | 0.22% | +22.6% |
Q1 2022 | $7,134,000 | +28.3% | 226,050 | +64.5% | 0.18% | +55.3% |
Q4 2021 | $5,560,000 | +52.1% | 137,387 | +31.0% | 0.11% | +65.2% |
Q3 2021 | $3,656,000 | – | 104,848 | – | 0.07% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Invus Financial Advisors, LLC | 1,842,077 | $64,233,000 | 17.21% |
Octagon Capital Advisors LP | 970,164 | $33,830,000 | 8.33% |
Copernicus Capital Management, LLC | 17,000 | $593,000 | 7.18% |
EcoR1 Capital, LLC | 5,122,359 | $178,617,000 | 6.21% |
BVF INC/IL | 3,229,822 | $112,624,000 | 4.39% |
PFM Health Sciences, LP | 3,431,010 | $119,639,000 | 3.52% |
Alphabet Inc. | 4,100,475 | $142,984,000 | 3.39% |
Boxer Capital, LLC | 2,084,883 | $72,700,000 | 2.54% |
SECTORAL ASSET MANAGEMENT INC | 739,010 | $25,769,000 | 2.14% |
Parkman Healthcare Partners LLC | 236,637 | $8,252,000 | 2.09% |